- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about XLV
Recent news which mentions XLV
UnitedHealth’s shares on track for biggest gain in over two years after earnings beat expectations
July 14, 2023
From MarketWatch
From MarketWatch
D.R. Horton, Shake Shack And A Home Construction Company Up 32% This Year: CNBC's 'Final Trades'
June 21, 2023
From Benzinga
Merck lawsuit challenging Medicare drug price negotiation signals long battle ahead, experts say
June 06, 2023
From MarketWatch
Biden administration rolls out new efforts on AI, including R&D plan and Education Dept. report
May 23, 2023
From MarketWatch
From ETF Trends
CVS Health reports 11% sales growth but cuts full-year earnings outlook as Oak Street deal closes
May 03, 2023
From MarketWatch
As Biden officially launches his re-election bid, inflation remains a top worry for voters
April 25, 2023
From MarketWatch
UnitedHealth’s stock reverses lower amid concerns over changes to Medicare Advantage rates
April 14, 2023
From MarketWatch
From MarketWatch
Recession Playbook In Action: Cooling Labor Market Triggers Rally In Treasuries, Gold; Stocks Decline
April 04, 2023
From Benzinga
Here’s one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
March 22, 2023
From MarketWatch
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
March 10, 2023
From Benzinga
Weekly Asset Flows: There’s Gold in Those ETFs
March 08, 2023
From ETF Trends
From Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
From Benzinga
The Wall Street chorus may be bearish, but this strategist points out stocks do better when earnings fall
February 28, 2023
From MarketWatch
A Bull Market Is Coming. Should You Return to Growth Stocks?
February 11, 2023
From Motley Fool
Biden criticizes DeSantis over his Medicaid stance while in Florida
February 09, 2023
From MarketWatch
Health-insurance stocks drop after Medicare Advantage proposes lower rates for 2024
February 02, 2023
From MarketWatch
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
February 02, 2023
From Motley Fool
The ‘Mother of All Bubbles’ has popped. This strategist sees a Fed-fueled recession in 2023.
January 24, 2023
From MarketWatch
The most unpopular portfolio in America wins in 2022 — again
January 18, 2023
From MarketWatch
Biden, Trump, DeSantis: Cramer Says Concerns Over Next President Mean We May Be In For 'Second Leg' Of 'Vicious Rotation' Out Of Healthcare
January 10, 2023
Tickers
XLV
From Benzinga
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
January 04, 2023
From Motley Fool
Leading And Lagging Sectors For January 3, 2023
January 03, 2023
From Benzinga
What the end of the stock market’s ‘FANG-era’ means for ETFs
December 22, 2022
From MarketWatch
Chart of the Week: Advisors Favored Vanguard But Horse Race is Tight
December 22, 2022
From ETF Trends
Democratic incumbent Warnock wins Georgia’s Senate runoff election — here’s why it matters
December 06, 2022
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.